Start with the exact material record
Match the storage instruction to the product, form and variant. Do not copy a temperature from another peptide, a reconstituted preparation or an unrelated supplier page. Where the public record does not establish a condition, ask for clarification before ordering.
Keep the page or document version used for the procurement decision together with the batch reference. This makes later review possible if wording changes.
Separate dispatch claims from stability evidence
A carrier transit estimate describes logistics, not material stability. Packaging language, route duration and tracking can support a transport plan, but they do not prove that every excursion is acceptable.
A buyer with a controlled-temperature requirement should agree the shipping condition and evidence before payment. The absence of a monitor should never be represented as proof that no excursion occurred.
Document receipt and exceptions
At receipt, record the order, product, batch, date, packaging condition and any observable concern. If temperature monitoring was specified, preserve the monitor result and review it under the receiving procedure.
Quarantine or disposition decisions belong to the buyer's qualified process. Supplier support can provide shipment and product records but should not invent an acceptance decision for a laboratory it does not control.
- Order and batch
- Dispatch and receipt timestamps
- Carrier and tracking reference
- Package condition
- Monitor result when specified
- Exception decision and responsible reviewer
Preserve handling history
Record storage location, access or movement events, and any change of container or label. Keep supplied material instructions distinct from a laboratory's study-specific preparation protocol.
EU medicinal-product distribution rules are not automatically the legal framework for research-only materials. They can illustrate controlled documentation principles, but a seller should not claim GDP or GMP status without verified scope and evidence.